← All stocks

PUMA BIOTECHNOLOGY, INC.

PBYI Mostly scheduled

CIK 0001401667 #3143 in the set updated 17 Sep 2026

Bought (12 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (12 mo)

$2.12M

$1.45M on a plan · $566.99K straight out of an exercise

Sold at will

$97.23K

1 of 17 sales

Net

−$2.12M

−$97.23K against sales at will

By person

11 insiders · 17 transactions

71.1×

Alan H. Auerbach holds 71.1 times base salary in stock. $66.25M of shares against $931.33K in salary for 2025.

Salary from the company's own proxy. The shares are what Alan H. Auerbach last reported holding, valued at $9.12, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

AUERBACH ALAN H

President and CEO

—

$568.93K (3) scheduled

−$568.93K

7,261,671

14.07%

$66.25M

+2.8%

Cesano Alessandra

Director

—

$566.99K (1) scheduled

−$566.99K

56,700

0.1098%

$517.27K

+5.0%

Senderowicz Adrian

Director

—

$194.31K (1) scheduled

−$194.31K

27,000

0.0523%

$246.32K

0.0%

MOYES JAY M

Director

—

$158.80K (1) scheduled

−$158.80K

58,322

0.1130%

$532.07K

+20.7%

NOUGUES MAXIMO F

Chief Financial Officer

—

$141.74K (3) scheduled

−$141.74K

230,637

0.4468%

$2.10M

+41.9%

WILSON TROY EDWARD

Director

—

$123.25K (2) scheduled

−$123.25K

55,300

0.1071%

$504.50K

+98.2%

HUNT DOUGLAS M

See Remarks

—

$122.60K (3) scheduled

−$122.60K

196,841

0.3813%

$1.80M

+47.7%

MILLER MICHAEL PATRICK

Director

—

$97.23K (1)

−$97.23K

81,000

0.1569%

$738.96K

+72.3%

Dorval Allison

Director

—

$83.58K (1) scheduled

−$83.58K

90,780

0.1759%

$828.19K

+51.3%

Stuglik Brian M

Director

—

$58.31K (1) scheduled

−$58.31K

113,858

0.2206%

$1.04M

+49.7%

Ludwig Jeffrey Jerome

Chief Commercial Officer

—

156,792

0.3037%

$1.43M

+32.4%

PUMA BIOTECHNOLOGY, INC.

By person

Individual transactions

What was left out